MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2024 International Congress

    Evaluation of Infusion Site Adverse Events With Foslevodopa/Foscarbidopa in a 12-Week, Randomized Study

    S. Isaacson, R. Kirsner, O. Vaou, R. Pahwa, R. Hauser, L. Bergmann, R. Gupta, M. Shah, S. Varughese, T. Kimber (Boca Raton, USA)

    Objective: To characterize infusion site events (ISEs) in patients with advanced Parkinson’s disease (aPD) treated with foslevodopa/foscarbidopa (LDp/CDp). Background: ISEs, including local reactions and infusion…
  • 2024 International Congress

    Lithium Therapy Associated with Reductions in Serum Neurofilament Light Chain (NfL) in Parkinson’s Disease.

    T. Guttuso, JR., R. Shepherd (Williamsville, USA)

    Objective: To assess the effects of lithium aspartate and lithium carbonate therapy for 24 weeks on serum NfL in Parkinson’s disease (PD). Background: Lithium has…
  • 2024 International Congress

    Boosting Clinical Trial Power in Parkinson’s Disease with AI-Generated Digital Twins

    C. Murray, C. Kusiak, A. Vanderbeek, D. Bertolini, E. Tramel (San Francisco, USA)

    Objective: To evaluate the incorporation of prognostic digital twins to enhance traditional clinical trials in Parkinson’s Disease (PD) for disease modifying therapies. We assess the…
  • 2024 International Congress

    A Conversational GPT Agent for Parkinson’s Disease

    B. Várkuti, L. Manola, M. Atayi, L. Liemen, G. van Elswijk, F. Lange, M. Reich, L. Erōss, M. Okun, J. Volkmann (München, Germany)

    Objective: To create a conversational chat agent that can provide persons with Parkinson’s with information about their disease. Background: Artificial intelligence using Large Language Models…
  • 2024 International Congress

    Wearable Device for Real-Time Prevention of Freezing-of-Gait in Parkinson’s Disease

    A. Alakhras, S. Pardoel, E. Jafari, J. Kofman, E. Lemaire, J. Nantel (Ottawa, Canada)

    Objective: In our previous work, we developed machine learning models to predict and detect freezing-of-gait (FOG) [1]. In this study, we aimed to use those…
  • 2024 International Congress

    Reliability of real-world walking activity and gait assessment in people with Parkinson’s disease – how many hours and days are needed?

    J. Buekers, J. Marchena, S. Koch, J. Lemos, J. Cherdova, C. Becker, T. Bonci, J. Braun, B. Caulfield, A. Frei, E. Gazit, J. Hausdorff, A. Mirelman, S. Del Din, L. Alcock, A. Yarnall, C. Jansen, M. Long, B. Sharrack, D. Singleton, C. Schlenstedt, W. Maetzler, H. Gassner, A. Ionescu, P. Ginis, A. Nieuwboer, L. Rochester, J. Garcia-Aymerich (Barcelona, Spain)

    Objective: To define i) the minimally required daily wear time during waking hours that constitutes a valid measurement of walking using digital mobility outcomes (DMOs)…
  • 2024 International Congress

    Cluster Analysis of Stimulation-Induced Dysarthria Subtypes in People with Parkinson’s Disease and Subthalamic Deep Brain Stimulation

    H. Jergas, JN. Petry-Schmelzer, JH. Hannemann, T. Thies, I. Rubi-Fessen, J. Quinting, V. Visser-Vandewalle, T. Tsuboi, MT. Barbe (Cologne, Germany)

    Objective: To establish different clusters with distinctive speech characteristics in people with Parkinson’s disease (PwPD) who experience stimulation-induced dysarthria (SID). Background: To date, the effect…
  • 2024 International Congress

    the Degeneration of Locus Coeruleus and its Enhanced Causal Relationship to Neural Circuit in Parkinson’s Tremor

    JY. Sun (Beijing, China)

    Objective: We aim to decode the neuroimaging features of LC in Parkinson's tremor. Background: Tremor is the primary symptom of Parkinson's disease (PD) and exhibits…
  • 2024 International Congress

    The Effects of Baduanjin on Fine Motor Skills in Mild and Moderate Parkinson’s Disease

    JUN. Li, KF. Li, HZ. Chen, WM. Yang (Hefei, China)

    Objective: To investigate whether Baduanjin Qigong exercise could help improve fine motor skills in patients with Parkinson's disease. Background: It is common for people with…
  • 2024 International Congress

    Integrated Clinical Research Intern Program: Impact Upon Recruitment of Participants for Therapeutic Studies Aimed at Parkinson’s Disease (PD) Prevention.

    L. Lemon, A. Faraday, J. Nevins, M. Nygard, M. Mcmahon (Cincinnati, USA)

    Objective: To discuss the development and benefit of an online internship program created to expand recruitment and retention within a PD cohort and introduce students…
  • « Previous Page
  • 1
  • …
  • 329
  • 330
  • 331
  • 332
  • 333
  • …
  • 1734
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley